Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products
- PMID: 13893560
- PMCID: PMC290991
- DOI: 10.1172/JCI104546
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products
Similar articles
-
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.J Clin Invest. 1962 Apr;41(4):917-34. doi: 10.1172/JCI104547. J Clin Invest. 1962. PMID: 13860492 Free PMC article. No abstract available.
-
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.J Clin Invest. 1962 Apr;41(4):935-48. doi: 10.1172/JCI104548. J Clin Invest. 1962. PMID: 13864646 Free PMC article. No abstract available.
-
Fibrinogen and fibrin degradation products in hemolytic transfusion reactions.Transfusion. 1970 Nov-Dec;10(6):317-21. doi: 10.1111/j.1537-2995.1970.tb00751.x. Transfusion. 1970. PMID: 5490098 No abstract available.
-
[Blood coagulation studies to discover the pathologically increased fibrinolytic activity of the blood that causes hemorrhage].Vutr Boles. 1978;17(3):41-5. Vutr Boles. 1978. PMID: 150133 Review. Bulgarian. No abstract available.
-
[Hemorrhagic diathesis due to coagulative and fibrinolytic abnormalities].Ryoikibetsu Shokogun Shirizu. 2000;(29 Pt 4):209-13. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11031932 Review. Japanese. No abstract available.
Cited by
-
Acute promyelocytic leukemia with hypofibrinogenemia.Calif Med. 1968 Sep;109(3):219-23. Calif Med. 1968. PMID: 5245524 Free PMC article. No abstract available.
-
A study of two methods for estimating plasma fibrinogen and the effect of epsilon aminocaproic acid and protamine.J Clin Pathol. 1971 Jul;24(5):467-71. doi: 10.1136/jcp.24.5.467. J Clin Pathol. 1971. PMID: 5571839 Free PMC article.
-
Thrombolysis in thromboembolic diseases.Ann Hematol. 1994 Oct;69(4):S41-57. doi: 10.1007/BF02215958. Ann Hematol. 1994. PMID: 7948299 Review.
-
Defibrination syndrome with defective thrombinfibrinogen reaction reversible by protamine.J Clin Pathol. 1965 Nov;18(6):786-9. doi: 10.1136/jcp.18.6.786. J Clin Pathol. 1965. PMID: 5891709 Free PMC article.
-
[Thromboelastographic studies on the blood clot structure in the Sanarelli-Shwartzman phenomenon].Klin Wochenschr. 1963 Mar 1;41:216-9. doi: 10.1007/BF01487695. Klin Wochenschr. 1963. PMID: 13936557 German. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources